Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes
- PMID: 20132659
- DOI: 10.1179/102453310X12583347009577
Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes
Abstract
Severe sepsis defined as infection-induced organ dysfunction or hypoperfusion abnormalities predispose to septic shock and increased mortality in neutropenic setting. We aimed at determining predictors of severe sepsis in neutropenic patients. Between 1 October and 31 December 2007, 41 patients (21 with acute myeloid leukemia, 19 with acute lymphoid leukemia and one with autologous stem cell transplantation for a mantle cell lymphoma) with chemotherapy-induced neutropenia (<0.5 x 10(9)/l) lasting for more than 7 days were included in this study. The median age was 28 years (range: 3-58 years). All patients were on oral antibacterial (colistin and gentamicin) and anti-fungal (amphotericin B) prophylaxis. The first neutropenic febrile episode was treated with piperacillin/tazobactam and colistin IV; if the patient remains febrile at 48 h from the start of this first line of treatment, amphotericin B i.v. is added. Imipenem was introduced in the case of non-response and finally glycopeptides were introduced according to the IDSA criteria. Severe sepsis and septic shock are defined according to the criteria of the consensus conference of the ACCP/SCCM excluding the leukocyte count since all the patients were neutropenic. Ninety-four febrile episodes were observed: 27 microbiologically documented (28.7%), six clinically documented (6.3%) and 61 fever of unknown origin (65%). Microbiologically documented infections were: 13 Gram-negative organisms, 11 Gram-positive organisms and three combined (Gram+ and -). Clinically documented infections were pneumonia (two), neutropenic enterocolitis (one), sinuses infection (one) and cutaneous infection (two). Severe sepsis accounted for 22 febrile episodes. Factors associated with the occurrence of severe sepsis were: hypophosphatemia (<0.8 mmol/l; p=0.05, OR=3.9, 95% CI: 1.3-45.7), hypoproteinemia (<62 g/l; p=0.006, OR=4.1, 95% CI: 1.4-11.4) and non-adapted antibiotherapy at the onset of severe sepsis (p=0.019, OR=2.7, 95% CI: 1.02-7.39). However, heart rate/systolic blood pressure ratio <1.1 (p<0.001, OR=0.1, 95% CI: 0.03-0.31) and Creactive protein <80 mg (p=0.001, OR=0.14, 95% CI: 0.04-0.54) were not predictive.
Similar articles
-
Predictive factors of septic shock and mortality in neutropenic patients.Hematology. 2007 Dec;12(6):543-8. doi: 10.1080/10245330701384237. Hematology. 2007. PMID: 17852435
-
Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.Front Cell Infect Microbiol. 2015 Feb 12;5:11. doi: 10.3389/fcimb.2015.00011. eCollection 2015. Front Cell Infect Microbiol. 2015. PMID: 25729741 Free PMC article.
-
Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia.Scand J Infect Dis. 2011 Jul;43(6-7):471-8. doi: 10.3109/00365548.2011.554855. Epub 2011 Feb 7. Scand J Infect Dis. 2011. PMID: 21299364
-
[Treatment of febrile neutropenia episodes in children, with a piperacillin-tazobactam and netilmicin combination].Med Mal Infect. 2005 Jun;35(6):357-62. doi: 10.1016/j.medmal.2005.04.004. Med Mal Infect. 2005. PMID: 15982848 Review. French.
-
Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.Eur J Haematol Suppl. 1993;54:18-24. doi: 10.1111/j.1600-0609.1993.tb01901.x. Eur J Haematol Suppl. 1993. PMID: 8365461 Review.
Cited by
-
Sepsis in the severely immunocompromised patient.Curr Infect Dis Rep. 2015 Jun;17(6):487. doi: 10.1007/s11908-015-0487-4. Curr Infect Dis Rep. 2015. PMID: 25939918
-
The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated With Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma.Front Oral Health. 2022 Jun 30;3:940044. doi: 10.3389/froh.2022.940044. eCollection 2022. Front Oral Health. 2022. PMID: 35846111 Free PMC article.
-
Independent factors for prediction of poor outcomes in patients with febrile neutropenia.Med Sci Monit. 2014 Oct 5;20:1826-32. doi: 10.12659/MSM.892269. Med Sci Monit. 2014. PMID: 25282155 Free PMC article.
-
Rapid Administration of Antibiotics for Reducing Fever Days in Patients Receiving Hematopoietic Stem Cell Transplantation.Medicina (Kaunas). 2022 Aug 25;58(9):1157. doi: 10.3390/medicina58091157. Medicina (Kaunas). 2022. PMID: 36143836 Free PMC article.
-
Microbiological Profile of Blood Stream Infections in Febrile Neutropenic Patients at a Tertiary Care Teaching Hospital in Rishikesh, Uttarakhand.J Lab Physicians. 2020 Aug;12(2):147-153. doi: 10.1055/s-0040-1716661. Epub 2020 Sep 2. J Lab Physicians. 2020. PMID: 32905287 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical